| http://www.w3.org/ns/prov#value | - Baxter's BioScience business is a leader in recombinant and plasma-based protein replacement therapies to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, burns and shock, and other rare blood-related conditions; products for regenerative medicine such as biosurgery wound healing products; and vaccines.
|
